Trial Profile
Alterations in Cognitive Function and Cerebral Blood Flow After Conversion From Immediate Release Tacrolimus to Slow Release Envarsus
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Apr 2021
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary) ; Tacrolimus
- Indications Renal transplant rejection
- Focus Therapeutic Use
- 26 Apr 2021 Status changed from active, no longer recruiting to completed.
- 01 Mar 2021 Planned End Date changed from 15 Feb 2021 to 15 Mar 2021.
- 01 Mar 2021 Planned primary completion date changed from 15 Jan 2021 to 26 Feb 2021.